Histone modification-linked prognostic model for ovarian cancer reveals LBX2 as a novel growth promoter
Favorite
Share
More Options
Fullscreen
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
